News
News
December 10, 2020
Information
Notice of Website Renewal
July 29, 2020
Press Releases
Summary Results of a Clinical Trial with Muse cell-based product, CL2020, in Patients with Epidermolysis Bullosa
June 17, 2020
Press Releases
Results of an Exploratory Clinical Trial with Muse cell-based product, CL2020, in Patients with Acute Myocardial Infarction Published in the Circulation Journal Online
April 23, 2020
Press Releases
A Summary Result of a Clinical Trial with Muse cell-based Product, CL2020, in Patients with Ischemic Stroke
April 23, 2020
Press Releases
A Summary Result of an Exploratory Clinical Trial with Muse cell-based product, CL2020, in Patients with Acute Myocardial Infarction
April 7, 2020
Information
Launch of New Company Brand Logo
March 12, 2020
Press Releases
Mitsubishi Chemical Holdings to Transfer Qualicaps' Business to Mitsubishi Chemical
August 7, 2019
Press Releases
Life Science Institute obtains a license for manufacturing of regenerative medicine products
August 1, 2019
Press Releases
Life Science Institute, Inc. Completes Share Exchange with PHC Holdings Corporation as Part of their Agreement on Strategic Capital Partnership
July 9, 2019
Press Releases
Initiation of a Clinical Trial with a Muse Cell Product in Patients with Spinal Cord Injuries
May 14, 2019
Press Releases
Life Science Institute Reaches Agreement on Strategic Capital Partnership with PHC Holdings
December 20, 2018
Press Releases
Initiation of an Exploratory Clinical Trial with a Muse Cell Product in Patients with Epidermolysis Bullosa
September 3, 2018
Press Releases
Initiation of an Exploratory Clinical Trial with a Muse Cell Product in Ischemic Stroke Patient
March 20, 2018
Press Releases
Establishment of Cell Processing Center for Muse Cell Products
January 15, 2018
Press Releases
Initiation of Exploratory Clinical Trial of Muse Cell Product Targeting Acute Myocardial Infarction
Go to another site
You are about to visit an external website (outside of the Life Science Institute, Inc. (LSII) homepage).
To leave this site, please click "Continue."